GlaxoSmithKline PLC (NYSE:GSK)

40.20
Delayed Data
As of 4:02pm ET
 +1.08 / +2.76%
Today’s Change
34.52
Today|||52-Week Range
44.54
+13.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line4.7B12.8B1.4B2.8B
 
 
 
 
 
Depreciation2.4B2.5B2.4B2.5B
 
 
 
 
 
Total Other Cash Flow-722.8M-14.9B1.8B1.7B
 
 
 
 
 
Funds From Operations6.4B360.0M5.6B6.6B
 
 
 
 
 
Funds From/For Other Operating Expenses-1.1B-2.6B-2.3B-1.4B
 
 
 
 
 
Net Cash Flow - Operating Activities7.5B2.9B7.9B8.0B
 
 
 
 
 
 
InvestingIncrease In Investments-151.5M-152.5M-144.0M-122.3M
 
 
 
 
 
Decrease In Investments340.8M1.4B919.1M340.0M
 
 
 
 
 
Capital Expenditures-2.0B-2.1B-2.1B-2.0B
 
 
 
 
 
Fixed Asset Disposal434.7M15.7B251.7M752.1M
 
 
 
 
 
Net Assets From Acquisitions -1.3B-5.4B0.00-154.5M
 
 
 
 
Other Investing - Uses0.000.00-98.2M0.00
 
 
Other Investing - Sources543.3M360.0M380.8M61.8M
 
 
 
 
 
Net Cash Flow Investing-3.0B9.0B-1.9B-2.0B
 
 
 
 
 
 
FinancingShort Term Borrowings-2.8B-3.6B129.2M-4.1B
 
 
 
 
 
Long Term Borrowings3.2B0.000.002.9B
 
 
 
Long Term Debt Reduction-37.9M-38.1M-24.2M-29.6M
 
 
 
 
 
Net Proceeds Stock Sale275.0M111.3M119.8M72.1M
 
 
 
 
 
Common Preferred Redeemed-548.3M-151.0M-99.6M-83.7M
 
 
 
 
 
Common Dividends-6.3B-5.9B-6.5B-5.0B
 
 
 
 
 
Cash Dividends Paid - Total-6.3B-5.9B-6.5B-5.0B
 
 
 
 
 
Other Sources - Financing0.00355.4M0.00119.8M
 
 
 
Other Uses - Financing358.9M361.5M1.3B1.0B
 
 
 
 
 
Net Cash Flow - Financing-6.6B-9.6B-7.7B-7.2B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash138.3M-68.6M380.8M-128.8M
 
 
 
 
 
 
Net Change In Cash-2.1B2.3B-1.6B-1.2B